Published in Gastroenterol Clin North Am on March 01, 1993
Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut (1996) 2.58
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
Ten year follow up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol (1995) 1.11
Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut (1999) 0.96
Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci (2000) 0.84
The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia. Gut (2005) 0.82
Nodular gastritis and pathologic findings in children and young adults with Helicobacter pylori infection. Yonsei Med J (2007) 0.82
Increased macrophage infiltration of gastric mucosa in Helicobacter pylori-infected children. Dig Dis Sci (2000) 0.81
Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci (1999) 0.78
Does serum nitrite concentration reflect gastric carcinogenesis in Japanese Helicobacter pylori-infected patients? Dig Dis Sci (2002) 0.77
Is peptic ulcer disease an infectious disease? West J Med (1993) 0.75
Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N Engl J Med (1983) 7.50
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet (1994) 3.22
Campylobacter fetus infection in human subjects: association with raw milk. Am J Med (1979) 2.99
The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesion and associated malabsorption. Gastroenterology (1971) 2.80
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol (1995) 2.73
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Symposium on pathology of the gastrointestinal tract-Part II. Small intestinal biopsy. Hum Pathol (1975) 2.40
Latent celiac sprue. Gastroenterology (1974) 2.36
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21
Sprue by any other name. Gastroenterology (1970) 2.21
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am J Surg Pathol (2000) 2.05
Electron microscopy of the intestine and rectum in acquired immunodeficiency syndrome. Gastroenterology (1985) 1.92
Primary abdominal lymphoma. Presenting manifestation of celiac sprue or complicating dermatitis herpetiformis. Am J Med (1977) 1.82
The small intestinal mucosa in dermatitis herpetiformis. II. Relationship of the small intestinal lesion to gluten. Gastroenterology (1971) 1.79
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med (1991) 1.67
The quality of care in Barrett's esophagus: endoscopist and pathologist practices. Am J Gastroenterol (2001) 1.63
Cytomegalovirus-associated gastric ulcer. Gastroenterology (1977) 1.53
Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut (1999) 1.48
Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation. Gastroenterology (1988) 1.44
Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc (1995) 1.41
The normal human esophageal mucosa: a histological reappraisal. Gastroenterology (1975) 1.35
Sulfasalazine-induced exacerbation of ulcerative colitis. N Engl J Med (1982) 1.32
Gastric dysplasia and its management. Gastroenterology (1994) 1.27
Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol (1999) 1.22
Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology (1996) 1.22
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res (1990) 1.20
The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc (1996) 1.19
Dysfunction of the continent ileostomy: clinical features and bacteriology. Gut (1983) 1.14
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc (2001) 1.06
Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers. Gastrointest Endosc (1995) 1.06
Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (1994) 1.05
Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopic lesions. Gastroenterology (1993) 1.04
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.04
Barrett's esophagus and adenocarcinoma. Annu Rev Med (1987) 0.99
Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology (1987) 0.98
Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (1994) 0.97
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. Ann Intern Med (1975) 0.97
Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol (1992) 0.95
Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev Infect Dis (1991) 0.93
Cytomegalovirus infection of the gastrointestinal tract in a patient with late onset immunodeficiency syndrome. Gastroenterology (1977) 0.93
Simultaneous visualization of two antigens in the same tissue section by combining immunoperoxidase with immunofluorescence techniques. J Histochem Cytochem (1979) 0.93
Barrett's esophagus in childhood. Gastroenterology (1985) 0.92
Subepithelial hemorrhages and erosions of human stomach. Dig Dis Sci (1988) 0.91
The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50-80 years old. Am J Gastroenterol (1997) 0.90
Artificial antigens. Antibody preparations for the localization of Lewis determinants in tissues. Biochemistry (1981) 0.90
Treatment of babesiosis in asplenic patients. JAMA (1981) 0.89
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Aliment Pharmacol Ther (1995) 0.86
Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. Hum Pathol (1996) 0.83
Epithelial cell renewal of the small intestinal mucosa. Med Clin North Am (1974) 0.83
The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol Suppl (1985) 0.82
Transport kinetics of D-glucose in human small intestinal mucosa: rate constants in histologically normal and abnormal mucosal biopsies. Dig Dis Sci (1979) 0.81
Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study. Am J Med (1985) 0.81
The diagnosis and classification of gastritis and duodenitis. J Clin Gastroenterol (1981) 0.80
Tissue-specific expression of c-Ha-ras in premalignant gastrointestinal mucosae. Exp Mol Pathol (1989) 0.79
Extending the scope in celiac disease. N Engl J Med (1988) 0.79
Immunoassay of pig and human gastric proton pump. Gastroenterology (1986) 0.79
Endoscopically directed fine needle aspiration biopsy of gastric and esophageal lesions. Acta Cytol (1992) 0.79
Prostatic abscesses involving anaerobic bacteria. Arch Intern Med (1978) 0.79
Comparison of kinetic constants of hexose uptake in four animal species and man. Comp Biochem Physiol A Comp Physiol (1982) 0.79
Vital staining of esophageal and gastric mucosa: not vital but may be helpful. Gastrointest Endosc (1993) 0.78
A restaining method to restore fluorescence in faded preparations of tissues treated with the indirect immunofluorescence technique. J Immunol Methods (1977) 0.78
Glycoconjugate expression in normal, metaplastic, and neoplastic human upper gastrointestinal mucosa. J Clin Invest (1987) 0.78
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial. Aliment Pharmacol Ther (2008) 0.77
Is Barrett's esophagus dangerous? Endoscopy (2002) 0.77
Gastrin cell immunofluorescence in conventionally fixed and stained tissue sections. Gastroenterology (1977) 0.76
Partial regression of childhood Barrett's esophagus after fundoplication. Am J Gastroenterol (1992) 0.76
Drug sequence-dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine. Cancer Res (1979) 0.76
Histological patchiness and sparing of the rectum in ulcerative colitis: refuting the dogma. J Clin Pathol (1997) 0.76
A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions. Prostaglandins (1981) 0.76
Cell death--where is thy sting? Gut (1996) 0.75
Misoprostol and NSAID. J Clin Gastroenterol (1991) 0.75
Rubella outbreak in a prenatal clinic: management and prevention. Am J Infect Control (1982) 0.75
"Shopping around" for drugs. N Engl J Med (1973) 0.75
Extending drug recalls--to include dispensed prescriptions. J Am Pharm Assoc (1969) 0.75
Gastroscopy for gastric ulcer. Gastroenterology (1977) 0.75
Crohn's disease. Can Med Assoc J (1972) 0.75
Absorption of digoxin. N Engl J Med (1972) 0.75
Campylobacter pylori in alcoholic hemorrhagic "gastritis". Dig Dis Sci (1989) 0.75
Lipid proctitis or lipid islands? N Engl J Med (1980) 0.75
Gastric biopsy. Gastrointest Endosc Clin N Am (2000) 0.75
Pathologist-gastroenterologist interaction. The changing role of the pathologist. Am J Clin Pathol (1995) 0.75
Intestinal uptake of fatty acids and cholesterol in four animals species and man: role of unstirred water layer and bile salt micelle. Comp Biochem Physiol A Comp Physiol (1983) 0.75